United States

People: Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

16 Mar 2018
Change (% chg)

$-0.04 (-0.53%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Given, Bruce 

Dr. Bruce D. Given, M.D., is Chief Operating Officer of Arrowhead Pharmaceuticals, Inc. He joined Arrowhead in 2011. Dr. Given was a member of the Board of Directors for ICON, plc. from 2004 until his retirement in 2013 and Chairman of its Board of Directors from 2010 to 2013. Dr. Given served as the President and Chief Executive Officer, and as a member of the Board of Directors of Encysive Pharmaceuticals, an R&D-based commercial pharmaceutical company, roles he held from 2002 through 2007. Subsequent to his tenure at Encysive until 2011, Dr. Given was President of Bruce Given Consulting, a firm that provides consulting services to biotech companies. Since October 1, 2009, Dr. Given has been a director of Calando Pharmaceuticals, Inc., and from February 2010 until its dissolution in October 2014, Dr. Given was the Chief Executive Officer of Leonardo Biosystems, Inc., in which Arrowhead held a minority equity interest. Prior to his tenure at Encysive, Dr. Given held several senior executive roles at Johnson and Johnson, Sandoz Pharmaceuticals and Schering-Plough. Dr. Given obtained his bachelor of sciences degree from Colorado State University, graduating Phi Beta Kappa. He received his M.D. degree with honors from the University of Chicago, Pritzker School of Medicine and completed his medical training at the University of Chicago and at Brigham and Women’s Hospital in Boston, where he was a Clinical Fellow at Harvard Medical School.

Basic Compensation

Total Annual Compensation, USD 682,631
Restricted Stock Awards, USD 922,500
Long-Term Incentive Plans, USD --
All Other, USD 287,974
Fiscal Year Total, USD 1,893,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --